Evidence map›Paper›PMID 18695130›Full record

ArticleJournal of the National Cancer Institute2008

Hepatitis B virus genotype and mutants: risk factors for hepatocellular carcinoma.

Josep M Llovet, Anna Lok

Abstract readCommentEditorial
In one paragraph

Article in Journal of the National Cancer Institute, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Non-Coding RNAs in Primary Liver Cancer.Frontiers in medicine · 2015
    Review
  5. Integration of genomic information in the clinical management of HCC.Best practice & research. Clinical gastroenterology · 2014
    Review
  6. Review
  7. Review
  8. Experimental models of hepatocellular carcinoma: developments and evolution.Journal of cancer research and clinical oncology · 2009
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Josep M Llovet
Anna Lok

Funding

Integrative genomic analysis in hepatocellular carcinomaR01DK076986 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI LLOVET, JOSEP M · 2007 to 2011
$1.3M
NIDDK NIH HHS 1R01DK076986-01
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MutationAntiviral AgentsAsia, EasternCarcinoma, HepatocellularEuropeGene FrequencyGenotypeHepatitis BHepatitis B Surface AntigensHepatitis B virusHumansLiver NeoplasmsRisk AssessmentRisk FactorsUnited StatesAntiviral AgentsHepatitis B Surface Antigens

Identifiers

PMID18695130
PMCPMC2720710

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.